Marie Navrátilová

ORCID: 0000-0003-1626-0694
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal cell carcinoma treatment
  • Cancer Genomics and Diagnostics
  • BRCA gene mutations in cancer
  • Renal and related cancers
  • Epigenetics and DNA Methylation
  • Cancer, Lipids, and Metabolism
  • Nutrition, Genetics, and Disease
  • Vitamin D Research Studies
  • Folate and B Vitamins Research
  • Carcinogens and Genotoxicity Assessment
  • Genetic Associations and Epidemiology
  • DNA Repair Mechanisms
  • Genetic factors in colorectal cancer
  • Cancer Risks and Factors
  • Occupational and environmental lung diseases
  • Glutathione Transferases and Polymorphisms
  • Air Quality and Health Impacts
  • Genomic variations and chromosomal abnormalities
  • Ovarian cancer diagnosis and treatment
  • Pelvic floor disorders treatments
  • Lipoproteins and Cardiovascular Health
  • Retinoids in leukemia and cellular processes
  • Ferroptosis and cancer prognosis
  • Global Cancer Incidence and Screening
  • Heavy Metal Exposure and Toxicity

Masaryk Memorial Cancer Institute
2015-2024

Carrier (United States)
2021

Cohort (United Kingdom)
2021

Národný Onkologický Ústav
2019

Institut Curie
2018

Inserm
2018

University Hospital Cologne
2018

University of Cologne
2018

University Hospital Ostrava
2015-2016

Palacký University Olomouc
2010

Abstract Purpose: To provide a comprehensive, thorough analysis of somatic mutation and promoter hypermethylation the von Hippel-Lindau (VHL) gene in cancer genome, unique to clear cell renal (ccRCC). Identify relationships between prevalence VHL alterations alteration subtypes with patient tumor characteristics. Experimental Design: As part large kidney case-control study conducted Central Europe, we analyzed mutations methylation 205 well-characterized, histologically confirmed biopsies...

10.1158/1078-0432.ccr-07-4921 article EN Clinical Cancer Research 2008-08-01

Abstract International differences in the incidence of many cancer types indicate existence carcinogen exposures that have not yet been identified by conventional epidemiology make a substantial contribution to burden 1 . In clear cell renal carcinoma, obesity, hypertension and tobacco smoking are risk factors, but they do explain geographical variation its 2 Underlying causes can be inferred sequencing genomes cancers from populations with different rates detecting patterns somatic...

10.1038/s41586-024-07368-2 article EN cc-by Nature 2024-05-01

Renal tumor heterogeneity studies have utilized the von Hippel-Lindau VHL gene to classify disease into molecularly defined subtypes examine associations with etiologic risk factors and prognosis. The aim of this study was provide a comprehensive analysis inactivation in clear cell renal tumors (ccRCC) evaluate relationships between subgroups cancer germline single nucleotide polymorphisms (SNPs). genetic epigenetic examined among 507 sporadic RCC/470 ccRCC cases using endonuclease scanning...

10.1371/journal.pgen.1002312 article EN cc-by PLoS Genetics 2011-10-13

Abstract Trichloroethylene (TCE) is a suspected renal carcinogen. TCE-associated genotoxicity occurs predominantly through glutathione S-transferase (GST) conjugation and bioactivation by cysteine β-lyase (CCBL1). We conducted case-control study in Central Europe (1,097 cases 1,476 controls) specifically designed to assess risk associated with occupational exposure TCE analysis of detailed job histories. All jobs were coded for organic/chlorinated solvent (ever/never) as well the frequency...

10.1158/0008-5472.can-09-4167 article EN Cancer Research 2010-07-28
Valentina Silvestri Daniel Barrowdale Anna Marie Mulligan Susan L. Neuhausen Stephen B. Fox and 95 more Beth Y. Karlan Gillian Mitchell Paul A. James Darcy L. Thull Kristin K. Zorn Natalie J. Carter Katherine L. Nathanson Susan M. Domchek Timothy R. Rebbeck Susan J. Ramus Robert L. Nussbaum Olufunmilayo I. Olopade Johanna Rantala Sook-Yee Yoon Maria A. Caligo Laura Spugnesi Anders Bojesen Inge Søkilde Pedersen Mads Thomassen Uffe Birk Jensen Amanda E. Toland Leigha Senter Irene L. Andrulis Gord Glendon Peter J. Hulick Evgeny N. Imyanitov Mark H. Greene L. Phuong Christian F. Singer Christine Rappaport Gero Kramer Joseph Vijai Kenneth Offit Mark E. Robson Anne Lincoln Lauren Jacobs Eva Macháčková Lenka Foretová Marie Navrátilová Petra Vašíčková Fergus J. Couch Emily Hallberg Kathryn J. Ruddy Priyanka Sharma Sung‐Won Kim Manuel R. Teixeira Pedro Pinto Marco Montagna Laura Matricardi Aðalgeir Arason Oskar T. Johannsson Rósa B. Barkardóttir Anna Jakubowska Jan Lubiński À. Izquierdo Miguel Ángel Pujana Judith Balmañà Orland Dı́ez Gabriella Ivády J. Papp Edith Oláh Ava Kwong Heli Nevanlinna Kristiina Aittomäki Pedro Pérez Segura Miguel de la Hoya Tom Van Maerken Bruce Poppe Kathleen Claes Claudine Isaacs Camille Elan Christine Lasset Dominique Stoppa‐Lyonnet Laure Barjhoux Muriel Belotti Alfons Meindl Andrea Gehrig Christian Sutter Christoph Engel Dieter Niederacher Doris Steinemann Eric Hahnen Karin Kast Norbert Arnold Raymonda Varon-Mateeva Dorothea Wand Andrew K. Godwin D. Gareth Evans Debra Frost Jo Perkins Julian Adlard Louise Izatt Radka Platte Rosalind A. Eeles Ian O. Ellis

BRCA1 and, more commonly, BRCA2 mutations are associated with increased risk of male breast cancer (MBC). However, only a paucity data exists on the pathology cancers (BCs) in men BRCA1/2 mutations. Using largest available dataset, we determined whether MBCs arising mutation carriers display specific pathologic features and these differ from those female BCs (FBCs). We characterised 419 using logistic regression analysis, contrasted 9675 FBCs population-based 6351 Surveillance, Epidemiology,...

10.1186/s13058-016-0671-y article EN cc-by Breast Cancer Research 2016-02-04
Mattias Johansson Robert Carreras‐Torres Ghislaine Scélo Mark P. Purdue Daniela Mariosa and 95 more David C. Muller Nicholas J. Timpson Philip Haycock Kevin M. Brown Zhaoming Wang Yuanqing Ye Jonathan N. Hofmann Matthieu Foll Valérie Gaborieau Mitchell J. Machiela Leandro M. Colli Peng Li Jean-Guillaume Garnier Hélène Blanché Anne Boland Laurie Burdette Egor Prokhortchouk K. G. Skryabin Meredith Yeager Sanja Radojević-Škodrić Simona Ognjanovic Lenka Foretová Ivana Holcátová Vladimí­r Janout Dana Mateș Anush Mukeriya Ștefan Rașcu Давид Заридзе Vladimír Bencko Cezary Cybulski Eleonóra Fabiánová Viorel Jinga Jolanta Lissowska Jan Lubiński Marie Navrátilová Péter Rudnai Simone Benhamou Géraldine Cancel‐Tassin Olivier Cussenot Elisabete Weiderpass Börje Ljungberg Raviprakash T. Sitaram Christel Häggström Fiona Bruinsma Susan J. Jordan Gianluca Severi Ingrid Winship Kristian Hveem Lars J. Vatten Tony Fletcher Susanna C. Larsson Alicja Wolk Rosamonde E. Banks Peter J. Selby Douglas F. Easton Gabriella Andreotti Laura E. Beane Freeman Stella Koutros Satu Männistö Stephanie J. Weinstein Peter E. Clark Todd L. Edwards Loren Lipworth Susan M. Gapstur Victoria L. Stevens Hallie Carol Matthew L. Freedman Mark M. Pomerantz Eunyoung Cho Kathryn M. Wilson J. Michael Gaziano Howard D. Sesso Neal D. Freedman Alexander S. Parker Jeanette E. Eckel‐Passow Wen‐Yi Huang Richard J. Kahnoski Brian R. Lane Sabrina L. Noyes David Petillo Bin Tean Teh Ulrike Peters Emily White Garnet L. Anderson Lisa Johnson Juhua Luo Julie E. Buring I‐Min Lee Wong‐Ho Chow Lee E. Moore Timothy Eisen Marc Henrion James Larkin Poulami Barman Bradley C. Leibovich

Background Several obesity-related factors have been associated with renal cell carcinoma (RCC), but it is unclear which individual directly influence risk. We addressed this question using genetic markers as proxies for putative risk and evaluated their relation to RCC in a mendelian randomization (MR) framework. This methodology limits bias due confounding not affected by reverse causation. Methods findings Genetic obesity measures, blood pressure, lipids, type 2 diabetes, insulin, glucose...

10.1371/journal.pmed.1002724 article EN public-domain PLoS Medicine 2019-01-03

Germline mutations in BRCA1 and BRCA2 account for majority of hereditary breast ovarian cancer. The complete coding sequence analysis both genes was carried out 197 breast/ovarian cancer patients from high-risk families 53 with sporadic In summary, 59 (16 different) 29 (17 were identified unrelated and/or index cases. Using the BIC Database numbering, most frequently found c.5385dupC (22 cases), c.3819_3823delGTAAA (8 cases) c.300T>G (6 cases). c.8138_8142delCCTTT (7 c.8765_8766delAG...

10.1002/humu.9226 article EN Human Mutation 2004-01-01
Xifeng Wu Ghislaine Scélo Mark P. Purdue Nathaniel Rothman Mattias Johansson and 87 more Yuanqing Ye Zhaoming Wang Diana Zélénika Lee E. Moore Christopher G. Wood Egor Prokhortchouk Valérie Gaborieau Kevin B. Jacobs Wong‐Ho Chow Jorge R. Toro Давид Заридзе Jie Lin Jan Lubiński Joanna Trubicka Neonilia Szeszenia‐Dabrowska Jolanta Lissowska Péter Rudnai Eleonóra Fabiánová Dana Mateș Viorel Jinga Vladimír Bencko Alena Slámová Ivana Holcátová Marie Navrátilová Vladimí­r Janout Paolo Boffetta Joanne S. Colt Faith G. Davis Kendra Schwartz Rosamonde E. Banks Peter J. Selby Patricia Harnden Christine D. Berg Ann W. Hsing Robert L. Grubb Heiner Boeing Paolo Vineis Françoise Clavel‐Chapelon Domenico Palli ­Rosario ­Tumino Vittorio Krogh Salvatore Panico Eric J. Duell J. Ramón Quirós María‐José Sánchez Carmen Navarro Eva Ardanáz Miren Dorronsoro Kay‐Tee Khaw Naomi E. Allen H. Bas Bueno-de-Mesquita Petra H. Peeters Dimitrios Trichopoulos Jakob Linseisen Börje Ljungberg Kim Overvad Anne Tjønneland Isabelle Romieu Elio Ríboli Victoria L. Stevens Michael J. Thun W. Ryan Diver Susan M. Gapstur Paul D.P. Pharoah Douglas F. Easton Demetrius Albanes Jarmo Virtamo Lars J. Vatten Kristian Hveem Tony Fletcher Kvetoslava Koppová Olivier Cussenot Géraldine Cancel‐Tassin Simone Benhamou Michelle A.T. Hildebrandt Xia Pu Mario Foglio Doris Lechner Amy Hutchinson Meredith Yeager Joseph F. Fraumeni Mark Lathrop K. G. Skryabin James McKay Jian Gu Paul Brennan Stephen J. Chanock

Renal cell carcinoma (RCC) is the most lethal urologic cancer. Only two common susceptibility loci for RCC have been confirmed to date. To identify additional loci, we conducted an independent genome-wide association study (GWAS). We analyzed 533 191 single nucleotide polymorphisms (SNPs) with in 894 cases and 1516 controls of European descent recruited from MD Anderson Cancer Center primary scan, validated top 500 SNPs silico 3772 8505 involved only published GWAS RCC. identified variants...

10.1093/hmg/ddr479 article EN Human Molecular Genetics 2011-10-18

Abstract Background The effect of risk-reducing salpingo-oophorectomy (RRSO) on breast cancer risk for BRCA1 and BRCA2 mutation carriers is uncertain. Retrospective analyses have suggested a protective but may be substantially biased. Prospective studies had limited power, particularly carriers. Further, previous not considered the RRSO in context natural menopause. Methods A multi-centre prospective cohort 2272 1605 was followed mean 5.4 4.9 years, respectively; 426 women developed incident...

10.1186/s13058-020-1247-4 article EN cc-by Breast Cancer Research 2020-01-16
Lieske H. Schrijver Antonis C Antoniou Håkan Olsson Thea M. Mooij Marie-José Roos-Blom and 95 more Leyla Azarang Julian Adlard Munaza Ahmed Daniel Barrowdale Rosemarie Davidson Alan Donaldson Rosalind A. Eeles D. Gareth Evans Debra Frost Alex Henderson Louise Izatt Kai-Ren Ong Valérie Bonadona Isabelle Coupier Laurence Faivre Jean‐Pierre Fricker Paul Gesta Klaartje van Engelen Agnes Jager Fred H. Menko Marian J.E. Mourits Christian F. Singer Yen Y. Tan Lenka Foretová Marie Navrátilová Rita K. Schmutzler Carolina Ellberg Anne–Marie Gerdes Trinidad Caldés Jacques Simard Edith Oláh Anna Jakubowska Johanna Rantala Ana Osório John L. Hopper Kelly‐Anne Phillips Roger L. Milne Mary Beth Terry Catherine Noguès Christoph Engel Karin Kast David E. Goldgar Flora E. van Leeuwen Douglas F. Easton Nadine Andrieu Matti A. Rookus Catherine Noguès Lilian Laborde Pauline Pontois Emanuelle Breysse Margot Berline Dominique Stoppa-Lyonnet Marion Gauthier‐Villars Bruno Buecher Chrystelle Colas Olivier Caron Catherine Noguès Emmanuelle Mouret‐Fourme Claire Saule Chrystelle Colas Jean-Pierre Fricker Christine Lasset Valérie Bonadona Sophie Dussard Pascaline Berthet Laurence Faivre Elisabeth Luporsi Véronique Mari Laurence Gladieff Paul Gesta Stéphanie Chieze-Valéro Jessica Moretta Hagay Sobol François Eisinger Cornel Popovici Michel Longy Louise Grivelli Chrystelle Colas Florent Soubrier Patrick Benusiglio Isabelle Coupier Pascal Pujol Carole Corsini Marie-Emmanuelle Morin-Meschin Alain Lortholary Claude Adenis A. Maillez Tan Dat Nguyen Capucine Delnatte Caroline Abadie Julie Tinat Isabelle Tennevet Christine Maugard Yves‐Jean Bignon Mathilde Gay Bellile

Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been shown to decrease with longer duration of oral contraceptive use. Although the effects using contraceptives general population are well established (approximately 50% reduction ovarian cancer), estimated is much less precise because potential bias small sample sizes. In addition, only a few studies on use have examined associations use, time since last starting age, calendar year start cancer.

10.1016/j.ajog.2021.01.014 article EN cc-by-nc-nd American Journal of Obstetrics and Gynecology 2021-01-22

The incidence of breast cancer has doubled over the past 20 years in Czech Republic. Hereditary factors may be a cause young onset, bilateral or ovarian cancer, and familial accumulation disease. BRCA1 BRCA2 mutations account for an important fraction hereditary cases. One thousand ten unrelated high-risk probands with and/or were analysed presence gene mutation at Masaryk Memorial Cancer Institute (Czech Republic) during 1999–2006. complete coding sequences splice sites both genes screened,...

10.1186/1471-2407-8-140 article EN cc-by BMC Cancer 2008-05-20

Array comparative genomic hybridization was used to identify copy number alterations in clear cell renal carcinoma (ccRCC) patient tumors associations with patient/clinical characteristics. Of 763 ccRCC patients, 412 (54%) provided frozen biopsies. Clones were analyzed for significant differences, adjusting multiple comparisons and covariates multivariate analyses. Frequent included losses on: 3p (92.2%), 14q (46.8%), 8p (38.1%), 4q (35.4%), 9p (32.3%), 9q (31.8%), 6q (30.8%), 3q (29.4%),...

10.1038/oncsis.2012.14 article EN cc-by Oncogenesis 2012-06-25

Abstract Recent genomic studies of sporadic clear cell renal carcinoma (ccRCC) have uncovered novel driver genes and pathways. Given the unequal incidence rates among men women (male:female ratio approaches 2:1), we compared genome-wide distribution chromosomal abnormalities in both sexes. We observed a higher frequency for somatic recurrent copy number variations (CNVs) autosomes male subjects, whereas loss chromosome X was detected exclusively female patients (17.1%). Furthermore, Y (LOY)...

10.1038/srep44876 article EN cc-by Scientific Reports 2017-03-23

Abstract Background For BRCA1 and BRCA2 mutation carriers, the association between oral contraceptive preparation (OCP) use breast cancer (BC) risk is still unclear. Methods Breast camcer associations were estimated from OCP data on 6030 3809 carriers using age-dependent Cox regression, stratified by study birth cohort. Prospective, left-truncated retrospective full-cohort analyses performed. Results was not associated with BC in prospective (hazard ratio [HR] = 1.08, 95% confidence interval...

10.1093/jncics/pky023 article EN cc-by-nc JNCI Cancer Spectrum 2018-04-01

Abstract Purpose: Patients with resected localized clear-cell renal cell carcinoma (ccRCC) remain at variable risk of recurrence. Incorporation biomarkers may refine prediction and inform adjuvant treatment decisions. We explored the role tumor genomics in this setting, leveraging largest cohort to date ccRCC tissues subjected targeted gene sequencing. Experimental Design: The somatic mutation status 12 genes was determined 943 cases from a multinational patients, associations outcomes were...

10.1158/1078-0432.ccr-22-1936 article EN cc-by-nc-nd Clinical Cancer Research 2023-02-23

High consumption of cruciferous vegetables has been associated with reduced kidney cancer risk in many studies. Isothiocyanates, thought to be responsible for the chemopreventive properties this food group, are conjugated glutathione by S -transferases ( GSTs ) before urinary excretion. Modification relationship host genetic factors is unknown. We investigated vegetable intake 1097 cases and 1555 controls enrolled a multicentric case–control study from Czech Republic, Poland, Romania Russia....

10.1093/carcin/bgm151 article EN Carcinogenesis 2007-07-07

We conducted a case-control study of renal cancer (987 cases and 1298 controls) in Central Eastern Europe analyzed genomic DNA for 319 tagging single-nucleotide polymorphisms (SNPs) 21 genes involved cellular growth, differentiation apoptosis using an Illumina Oligo Pool All (OPA). A haplotype-based method (sliding window analysis consecutive SNPs) was used to identify chromosome regions interest that remained significant at false discovery rate 10%. Subsequently, risk estimates were...

10.1371/journal.pone.0004895 article EN cc-by PLoS ONE 2009-03-23

Purpose Leukocyte global DNA methylation levels are currently being considered as biomarkers of cancer susceptibility and have been associated with risk several cancers. In this study, we aimed to examine the association between long interspersed nuclear elements (LINE-1) levels, a biomarker in blood cell DNA, renal risk. Experimental Design LINE-1 bisulfite-converted genomic isolated from leukocytes was quantified by pyrosequencing measured triplicate, averaged across 4 CpG sites. A total...

10.1371/journal.pone.0027361 article EN cc-by PLoS ONE 2011-11-04

To investigate whether occupational exposure to polycyclic aromatic hydrocarbons and certain plastic monomers increased renal cell carcinoma (RCC) risk.

10.1097/jom.0b013e31820a40a3 article EN Journal of Occupational and Environmental Medicine 2011-01-27

It was hypothesized that increasing the time for which onabotulinum toxin A (OnabotA) is exposed to urothelium following intravesical instillation will augment its effect. TC-3 an inert heat-sensitive hydrogel, creates bulk providing a slow release of embedded drug after instillation. The aim this study evaluate effect OnabotA, in patients with idiopathic overactive bladder (OAB).In total, 39 female (age 30-65, average 53.8 years) OAB symptoms were randomized into four groups, each receiving...

10.3109/21681805.2015.1121406 article EN Scandinavian Journal of Urology 2016-01-12

Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) is a rare variant familial adenomatous polyposis. It an autosomal-dominant cancer-predisposition syndrome with massive significant risk gastric adenocarcinoma. Li et al., 2016, described point mutations in Ying Yang 1 binding site APC gene 1B promoter associated GAPPS syndrome. The first Czech family was 2016. At Masaryk Memorial Cancer Institute, diagnosed eight families using Sanger sequencing. In all families, one...

10.14735/amko2019s109 article EN Klinicka onkologie 2019-08-15
Coming Soon ...